Bioiberica to present their active pharmaceutical ingredients and branded products at CPhI China 2019

Bioiberica, a global life science company, is fully committed to improve the healthcare and wellbeing of persons. For one more year, Bioiberica will be present at CPhI China, one of the most strategic events for our company in Asia. This is the most important event for the Chinese pharmaceutical industry and the Asia-Pacific region. Held since 2001, this years’ edition (Shanghai New International Expo Centre, 18-20 June 2019) will have more than 200,000 m² of exhibition area (with more than 3,200 exhibitors) and will be attended by more than 50,000 professionals representing leading firms from Asia, Europe, the Americas, and the MENA region.

At CPhI 2019, professionals can find new products, learn about the latest trends and regulations of the market, and establish business contacts with all industry sectors. CPhI covers all the stages of the pharmaceutical supply chain, from APIs (Active Pharmaceutical Ingredients) to finished products. Bioiberica will be presenting their APIs, such as heparin, chondroitin sulfate, glucosamine and tyroid. They will also put the focus on their branded ingredients (b2cool^®, Tendoactive^®, Mobilee^®).

Bioberica, is a world leader in the production of heparin, an active pharmaceutical ingredient, and a global reference in the research, production and marketing of other active ingredients and compounds of animal origin such as chondroitin sulfate, glucosamine, hyaluronic acid, native collagen Type II or tyroid, would like to invite visitors and professionals to attend our booth E1Q10 and receive detailed information on the wide range of solutions we can offer them.